Clinical trial
Treatment-Resistant Depression Registry
NCT00320372 · Cyberonics, Inc., Industry · Completed
Key facts
| NCT number | NCT00320372 |
|---|---|
| Title | Treatment-Resistant Depression Registry |
| Official title | A Long-term, Prospective, Observational, Multi-center Patient Outcome Registry to Collect Data in Patients With Treatment-resistant Depression (TRD) Who Are Currently in a Major Depressive Episode. |
| Lead sponsor | Cyberonics, Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Major Depressive Disorder |
| Enrollment | 795 |
| Start date | Jan 1, 2006 |
| Primary completion | Mar 1, 2015 |
| Completion | May 1, 2015 |
| First posted | May 3, 2006 |
| Last update posted | Dec 23, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: